Taiwan To Double Stockpile Of Tamiflu, Relax Regs For Flu Drugs
This article was originally published in PharmAsia News
Executive Summary
Taiwan health authorities decided to increase the nation's supply of Roche's Tamiflu (oseltamivir) - enough to treat 7 million against the H1N1 flu virus. A stockpile that size would be enough to treat about 30 percent of Taiwan's population, beyond the current supply able to treat 14 percent. The flu-prevention task force also decided to relax some regulations to allow expanded use of the antiviral as the peak season for the flu neared Taiwan. The country also has a stockpile of shikimic acid, the active pharmaceutical ingredient in Tamiflu, enough to cover 4 percent. (Click here for more